Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Malaysia · Delayed Price · Currency is MYR

2.010

-0.030 (-1.47%)

At close: Aug 11, 2026

-6.94% (1Y)

Market Cap	289.36M -5.6%
Revenue (ttm)	363.14M +0.1%
Net Income	23.50M -2.0%
EPS	0.17 -2.1%
Shares Out	141.84M
PE Ratio	12.32
Forward PE	n/a
Dividend	0.11 (5.45%)
Ex-Dividend Date	Jun 26, 2026

Volume	31,900
Open	2.010
Previous Close	2.040
Day's Range	2.010 - 2.020
52-Week Range	2.010 - 2.200
Beta	-0.00
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also m... [Read more]

Industry Pharmaceutical Preparations

Founded 1987

Employees 1,361

Stock Exchange Bursa Malaysia

Ticker Symbol YSPSAH

Full Company Profile

Financial Performance

In 2025, KLSE:YSPSAH's revenue was 365.12 million, a decrease of -0.96% compared to the previous year's 368.66 million. Earnings were 25.03 million, a decrease of -6.21%.

Financial Statements